Global Prenatal DNA Sequencing Market
Global Prenatal DNA Sequencing Market Review 2018-2023 and Forecast to 2028: Non-Invasive Sequencing Revolutionizing Prenatal Care, Offering Comprehensive Early Insights and Enhanced Personalized Medicine
20 févr. 2024 04h02 HE | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Prenatal DNA Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Fetal Monitoring, Diagnostics and Predictive Tests Market
Fetal Monitoring, Diagnostics and Predictive Tests Global Market Report 2023: Featuring Abbott Laboratories, Abcam, Ansh Labs, Beckman Coulter, Contect Medical Systems Co. and Dragerwerk
04 avr. 2023 08h28 HE | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Fetal Monitoring, Diagnostics and Predictive Tests" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a...
Global Market for Prenatal Diagnostics
Prenatal Diagnostics Global Market Report 2023: Conventional Invasive Techniques Loose Sheen, Presenting Opportunities for Innovation
09 mars 2023 08h18 HE | Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Prenatal Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Prenatal Diagnostics Market...
U.S. Women Health Laboratory Testing Market
United States Women Health Laboratory Testing Markets Report 2022: A $106 Billion Market by 2030 - Significant Number of Mergers and Acquisitions by Companies to Attain a Better Market Share
17 févr. 2023 04h18 HE | Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S. Women Health Laboratory Testing Market - Analysis and Forecast,...
Straits Research Pvt Ltd
Non-Invasive Prenatal Testing Market Size is projected to reach USD 7.96 billion by 2031, growing at a CAGR of 9.2%: Straits Research
01 déc. 2022 09h30 HE | Straits Research
New York, United States, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Prenatal non-invasive testing is used to check for genetic diseases such as Down syndrome, Edwards syndrome, and Patau syndrome in the...
Global Non-Invasive Prenatal Testing Market
Global Non-Invasive Prenatal Testing (NIPT) Market Report 2022-2027: Cell-Free DNA-Based NIPT Market Is Gauged to Generate the Highest Market Share
07 avr. 2022 05h58 HE | Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Global Non-Invasive Prenatal Testing (NIPT) Market, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report...
Global Market for Genetic Testing
Global Genetic Testing Market Report 2022: Market to Reach $17.3 Billion by 2026 - Genetic Testing Paves the Way for Personalized Medicine
24 mars 2022 09h08 HE | Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Genetic Testing Market...
22157.jpg
Exosome Diagnostics and Therapeutics - Global Market Size & Market Share Analysis by Application, End-user, and Geographic Region: 2019-2026
25 nov. 2021 05h38 HE | Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics and Therapeutics: Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for...
22157.jpg
Global Genetic Testing Market Report 2021: Market to Reach $17.3 Billion by 2026 - Predictive & Presymptomatic Segment to Reach $3 Billion
13 juil. 2021 03h33 HE | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Genetic Testing Market...
CombiMatrix Corporat
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
10 nov. 2017 16h15 HE | CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...